Avicanna Inc (AVCN) - Total Liabilities
Based on the latest financial reports, Avicanna Inc (AVCN) has total liabilities worth CA$9.86 Million CAD (≈ $7.13 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Avicanna Inc cash flow conversion to assess how effectively this company generates cash.
Avicanna Inc - Total Liabilities Trend (2016–2025)
This chart illustrates how Avicanna Inc's total liabilities have evolved over time, based on quarterly financial data. Check AVCN cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Avicanna Inc Competitors by Total Liabilities
The table below lists competitors of Avicanna Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
PT Mitra Pack Tbk
JK:PTMP
|
Indonesia | Rp104.19 Billion |
|
Berkah Beton Sadaya Tbk PT
JK:BEBS
|
Indonesia | Rp88.66 Billion |
|
Decade Resources Ltd
V:DEC
|
Canada | CA$569.83K |
|
Income Asset Management Group Ltd
AU:IAM
|
Australia | AU$7.68 Million |
|
Trust Stamp Inc
NASDAQ:IDAI
|
USA | $4.97 Million |
|
Thanasiri Group Public Company Limited
BK:THANA
|
Thailand | ฿579.66 Million |
|
Trematon Capital Investments
JSE:TMT
|
South Africa | ZAC367.68 Million |
|
Euro Manganese Inc
AU:EMN
|
Australia | AU$34.27 Million |
Liability Composition Analysis (2016–2025)
This chart breaks down Avicanna Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Avicanna Inc worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.86 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.47 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Avicanna Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Avicanna Inc (2016–2025)
The table below shows the annual total liabilities of Avicanna Inc from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CA$9.86 Million ≈ $7.13 Million |
-5.00% |
| 2024-12-31 | CA$10.38 Million ≈ $7.51 Million |
-25.89% |
| 2023-12-31 | CA$14.00 Million ≈ $10.13 Million |
-1.14% |
| 2022-12-31 | CA$14.16 Million ≈ $10.24 Million |
-8.01% |
| 2021-12-31 | CA$15.39 Million ≈ $11.14 Million |
-5.25% |
| 2020-12-31 | CA$16.25 Million ≈ $11.75 Million |
+6.26% |
| 2019-12-31 | CA$15.29 Million ≈ $11.06 Million |
+748.74% |
| 2018-12-31 | CA$1.80 Million ≈ $1.30 Million |
+41.13% |
| 2017-12-31 | CA$1.28 Million ≈ $923.33K |
+939.73% |
| 2016-12-31 | CA$122.76K ≈ $88.80K |
-- |
About Avicanna Inc
Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for consumer, medical, and pharmaceutical markets in Canada and internationally. It provides medical cannabis formulary products, including oral, sublingual, topical, and transdermal deliveries with vari… Read more